Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications understanding treatment preferences patients kras pg12clc1 mk2 ��� mutated advanced non
… (EMA) and US Food and Drug Administration (FDA) for cancer treatment found that the agencies use different standards to … by study authors and based on PRO labeling of cancer treatment drugs, focuses on key differences between the 2 …
… M, Doherty J, Mak C, Cutler AJ, Mattingly GW. Poster Preferences for characteristics of oral antipsychotic treatments: survey results of patients living with schizophrenia or bipolar I disorder. …
… economics Literature Reviews: Disease, burden of illness, treatment pathway, epidemiology and unmet need A Gap …
Longitudinal Modeling Approaches to Assess Association Between Two Clinical Outcomes Assessments Bintu Sherif, MS Director, Biostatistics Transcript With an increased regulatory focus on incorporating patient perspectives in drug development, …
Celebrating 20 Years of Research Share on: September 30, 2020 On October 1, 2000, RTI Health Solutions was officially launched under the leadership of Jo Mauskopf. Twenty years later, we're excited to have reached this milestone in our journey of …
… it compares to comparators); and clinical effectiveness. Non-clinical HTA domains, which mainly involve cost, economic … that access to innovative medicines is accelerated for EU patients in the EU. Whether the new legislation and … Consultations Joint scientific consultation is a non-binding scientific advice procedure in parallel …
DIA Global Annual Meeting 2022 Share on: Sunday, June 19 - Thursday, June 23, 2022 Conference Website McCormick Place West 2301 S Indiana Ave Chicago , IL 60616 United States Carol Mansfield, Senior Economist and Head, Health Preference Assessment, will …
… and improve shared healthcare decision making. From patients and caregivers to busy medical professionals and … this presentation, you will learn: The value of PLS for patients and other stakeholders as a source of trustworthy information about a disease and its treatment. The potential benefits of disseminating PLS to …
… Clinical and Economic Review, or ICER, is an independent, non-partisan research organization, specializing in …
… create reports for regulatory and HTA purposes as well as publications, interactive tools, and models to help you …